Ultram and Medroxyprogesterone acetate drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Ultram (tramadol hydrochloride) and Medroxyprogesterone acetate (medroxyprogesterone acetate). Common drug interactions include breast cancer female among females.
The phase IV clinical study analyzes what interactions people have when they take Ultram and Medroxyprogesterone acetate. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.
What is Ultram?
Ultram has active ingredients of tramadol hydrochloride. It is often used in pain. eHealthMe is studying from 28,425 Ultram users. Check the latest studies of Ultram.
What is Medroxyprogesterone acetate?
Medroxyprogesterone acetate has active ingredients of medroxyprogesterone acetate. It is often used in birth control. eHealthMe is studying from 12,600 Medroxyprogesterone acetate users. Check the latest studies of Medroxyprogesterone acetate.
11 people who take Ultram and Medroxyprogesterone acetate together, and have interactions are studied.
What are the common drug interactions of Ultram and Medroxyprogesterone Acetate, by gender? *:
female:
- Breast cancer female
- Breast cancer
- Drug dependence
- Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
- Gastrointestinal disorder (functional problems of gastrointestinal tract)
- Tolerance increased
male:
n/a
What are the common drug interactions of Ultram and Medroxyprogesterone Acetate, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Drug dependence
- Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
- Tolerance increased
40-49:
- Gastrointestinal disorder (functional problems of gastrointestinal tract)
50-59:
- Breast cancer female
- Breast cancer
60+:
- Breast cancer
What are the existing conditions these people have? *
- Nausea (feeling of having an urge to vomit): 7 people, 63.64%
- Migraine (headache): 5 people, 45.45%
- Depression: 5 people, 45.45%
- Muscle Spasms (muscle contraction): 3 people, 27.27%
- Gastric Ulcer (stomach ulcer): 3 people, 27.27%
- Ascites (accumulation of fluid in the abdominal cavity): 3 people, 27.27%
- Stress And Anxiety: 2 people, 18.18%
- Sleep Disorder: 2 people, 18.18%
- Asthma: 2 people, 18.18%
- Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 18.18%
* Approximation only. Some reports may have incomplete information.
Do you take Ultram and Medroxyprogesterone acetate?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Ultram (28,425 reports)
- Medroxyprogesterone acetate (12,600 reports)
Browse all drug interactions of Ultram and Medroxyprogesterone acetate:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Ultram:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Medroxyprogesterone acetate:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ultram and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Medroxyprogesterone acetate and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Bahall M, Reyes AJ, Ramcharan K, Hosein N, Seegobin K, Bahall K, Sharma H, Dhansingh S, Mahabir A, "Neuro-ophthalmological manifestations after intramuscular medroxyprogesterone: a forme fruste of idiopathic intracranial hypertension?", Neurology international, 2016 Sep .
- Mansour HM, "Tramadol and Disseminated Intravascular Coagulopathy: A Case Report", Medicine Science, 2015 Jan .
- Bahall M, Reyes AJ, Ramcharan K, Hosein N, Seegobin K, Bahall K, Sharma H, Dhansingh S, Mahabir A, "Neuro-ophthalmological manifestations after intramuscular medroxyprogesterone: a forme fruste of idiopathic intracranial hypertension?", Neurology international, 2016 Sep .
- Mansour HM, "Tramadol and Disseminated Intravascular Coagulopathy: A Case Report", Medicine Science, 2015 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on tramadol hydrochloride and medroxyprogesterone acetate (the active ingredients of Ultram and Medroxyprogesterone acetate, respectively), and Ultram and Medroxyprogesterone acetate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Topamax cause Pregnancy With Contraceptive Device? - 2 seconds ago
- Drug interactions of Glyburide and Novolin R - 2 seconds ago
- Zicam vs. Acyclovir, side effect and effectiveness comparison - 9 seconds ago
- Could Asacol cause Myopathy? - 11 seconds ago
- Drug interactions of Nicoderm Cq and Septra - 16 seconds ago
- Drug interactions of Klonopin and Oracea - 23 seconds ago
- Drug interactions of Kenalog and Vimpat - 34 seconds ago
- Drug interactions of Cytomel and Aranesp - 35 seconds ago
- Drug interactions of Rifater and Kaletra - 37 seconds ago
- Could Acephen cause Gingival Oedema? - 53 seconds ago